Jump Financial’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
Jump Financial's NUVB Position: Q3 2026 in Review
Jump Financial reduced its Nuvation Bio (NUVB) stake by 9.1% in Q3 2026, selling an estimated $772K and leaving 1,235,324 shares worth $6.92M. The position accounts for 0.05% of the portfolio, ranked #480.
Jump Financial first reported a position in NUVB in Q1 2022 and has held it in 7 quarters since. The position peaked at $7.72M in Q2 2026. 260 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.
- Jump Financial held 1,235,324 shares of Nuvation Bio worth $6.92M as of Q3 2026.
- Jump Financial sold 123,087 Nuvation Bio shares in Q3 2026, an estimated $772K.
- Nuvation Bio made up 0.05% of Jump Financial's portfolio in Q3 2026, its #480 holding.
- Jump Financial first reported a position in Nuvation Bio in Q1 2022 and has held it in 7 quarters since.
- Jump Financial's Nuvation Bio position peaked at $7.72M in Q2 2026.
- 260 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.